ロード中...
The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer
BACKGROUND: The treatment of differentiated thyroid cancer (DTC) ends in full recovery in 80% of cases. However, in 20% of cases local recurrences or distant metastases are observed, for this reason DTC patients are under life-long follow-up. The most sensitive marker for recurrence is stimulated th...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521804/ https://ncbi.nlm.nih.gov/pubmed/26230494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0133852 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|